SCHEMBL25871527

SCHEMBL25871527

N#Cc1cc2cc[nH]c2c(F)c1Br

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 2/20 0.43
▸ IMPDH2 P12268 1/20 0.39
▸ IMPDH1 P20839 1/20 0.39
▸ AHR P35869 4/20 0.34
▸ CYP2A6 P11509 1/20 0.34
▸ NR4A2 P43354 1/20 0.34
▸ XDH P47989 1/20 0.34
▸ SLC22A12 Q96S37 1/20 0.34
▸ DYRK1A Q13627 2/20 0.33
▸ PIM3 Q86V86 1/20 0.33
▸ TNF P01375 1/20 0.33
▸ RIPK1 Q13546 1/20 0.33
▸ IKBKB O14920 1/20 0.32
▸ CHUK O15111 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ ESR1 P03372 1/20 0.30
▸ ESR2 Q92731 1/20 0.30
▸ TRPV4 Q9HBA0 1/20 0.30
▸ MCL1 Q07820 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30950714 0.77 GPR84 (0.45) AHRCYP2A6NR4A2PIM3TNF
SCHEMBL1420429 0.75 AHR (0.47) CHEK1IMPDH2IMPDH1AHRXDH
SCHEMBL31357932 0.75 AHR (0.47) CHEK1IMPDH2IMPDH1AHRXDH
SCHEMBL30687262 0.75 TNF (0.44) CHEK1IMPDH2IMPDH1AHRTNF
SCHEMBL19611745 0.74 AHR (0.46) CHEK1IMPDH2IMPDH1AHRCYP2A6
SCHEMBL22076299 0.72 IMPDH2 (0.39) CHEK1IMPDH2IMPDH1AHRCYP2A6
SCHEMBL10179175 0.71 CSNK2A1 (0.41) AHRCYP2A6NR4A2PIM3TNF
SCHEMBL28834448 0.70 DYRK1A (0.36) CHEK1IMPDH2IMPDH1DYRK1ATNF
SCHEMBL35212610 0.70 TLR8 (0.37) TNFRIPK1IKBKBCHUKGPR84
SCHEMBL30840801 0.69 SLC22A12 (0.37) IMPDH2IMPDH1AHRSLC22A12DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023137634-A1 TRICYCLIC COMPOUND, PREPARATION THEREFOR, PHARMACEUTICAL COMPOSITION AND USE 上海奕拓医药科技有限责任公司 2023-07-27 — — WO disclosed
Send feedback